LWAM
MIRO

Legacy Wealth Asset Management’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Legacy Wealth Asset Management’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-91,701
Closed -$120K – 350
2023
Q3 		$120K Buy
91,701
+40,001
+77% +$58.4K 0.04% 328
2023
Q2 		$90.5K Buy
51,700
+1,164
+2% +$1.53K 0.03% 333
2023
Q1 		$84.9K Hold
50,536
– – 0.03% 331
2022
Q4 		$151K Hold
50,536
– – 0.06% 328
2022
Q3 		$221K Buy
50,536
+37,000
+273% +$120K 0.1% 297
2022
Q2 		$54K Buy
+13,536
New +$51.8K 0.02% 311

Legacy Wealth Asset Management's MIRO Position: Q4 2023 in Review

Legacy Wealth Asset Management sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 91,701 shares — an estimated $120K sold.

Legacy Wealth Asset Management first reported a position in MIRO in Q2 2022 and held it in 6 quarters. The position peaked at $221K in Q3 2022. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

  • Legacy Wealth Asset Management reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Legacy Wealth Asset Management sold 91,701 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $120K.
  • Legacy Wealth Asset Management first reported a position in Miromatrix Medical Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • Legacy Wealth Asset Management's Miromatrix Medical Inc. Common Stock position peaked at $221K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on Legacy Wealth Asset Management's 13F filing for Q4 2023, filed 10 Jan 2024.